RAG1 and infection: Particularly, the significant increase in the post-challenge clinical outcomes of ARPV/ZIKV-vaccinated Rag1 KO mice compared to vaccinated Tcra KO or muMt- KO mice may support the idea of a compensatory relationship between cellular- and humoral-mediated immunity during infection.